The Tumour Immune Microenvironment in Breast Ductal Carcinoma In Situ Progression to Invasive Cancer

乳腺导管原位癌进展为侵​​袭性癌症的肿瘤免疫微环境

• 批准号: 406635
• 负责人: Francis Alyssa V
• 金额: $ 1.27万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-12-01 至 2019-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406635&lang=en
• 关键词: Breast Cancer; Dcis; Immune System; Macrophages; Microenvironment; T Cells

Ductal carcinoma in situ (DCIS) comprises around 20% of all breast cancer diagnoses. DCIS, which can be considered as “stage 0 breast cancer”, is a collection of abnormal cells lining the ducts of breast tissue and has been shown to increase the likelihoo

导管原位癌（DCIS）约占所有乳腺癌诊断的20%。DCIS，可以被认为是“0期乳腺癌”，是一组排列在乳腺组织导管内的异常细胞，已被证明会增加乳腺癌的可能性。